Literature DB >> 8185720

Response of the endothelium to trauma and sepsis. Adherence, cytokine effects and procoagulatory response.

H Redl1, G Schlag, R Kneidinger, W Ohlinger, J Davies.   

Abstract

Trauma and sepsis induced organ dysfunction is the result of an overwhelming inflammatory response, in which the endothelium plays a central role. Within the mediator cascade reactions involve thrombin, histamine induced endothelial "stimulation" and endotoxin/cytokine induced endothelial "activation" in the endothelial/leukocyte interactions. Adherence events beyond the physiological degree lead to endothelial damage, increase of permeability and result in organ dysfunction. Activated endothelial cells are further involved in cytokine production and they are important actors in the procoagulatory/anticoagulatory balance. The homeostasis is disturbed in the systemic inflammatory response, which leads to a procoagulant state of the endothelium and severe coagulation disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8185720

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat.

Authors:  M T Heneka; P A Löschmann; H Osswald
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

Review 2.  Update on the role of endothelial cells in trauma.

Authors:  J Greven; R Pfeifer; Q Zhi; H C Pape
Journal:  Eur J Trauma Emerg Surg       Date:  2017-07-03       Impact factor: 3.693

3.  [Clinical course and complications of meningococcal septicemia].

Authors:  F Gradaus; R M Klein; H J von Giesen; G Arendt; M P Heintzen; M Leschke; B E Strauer
Journal:  Med Klin (Munich)       Date:  1999-11-15

4.  Lipopolysaccharide and interferon-gamma enhance Fas-mediated cell death in mouse vascular endothelial cells via augmentation of Fas expression.

Authors:  N Koide; A Morikawa; G Tumurkhuu; J Dagvadorj; F Hassan; S Islam; Y Naiki; I Mori; T Yoshida; T Yokochi
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.